Eosinophils and the release of cationic granule proteins have long been implicated in the development of the type 2-induced pathologies linked with respiratory inflammation. Paradoxically, the ablation of the two genes encoding the most abundant of these granule proteins, major basic protein-1 (MBP-1) and eosinophil peroxidase (EPX), results in a near collapse of eosinophilopoiesis. The specificity of this lineage ablation and the magnitude of the induced eosinopenia provide a unique opportunity to clarify the importance of eosinophils in acute and chronic inflammatory settings, as well as to identify potential mechanism(s) of action linked with pulmonary eosinophils in those settings. Specifically, we examined these issues by assessing the induced immune responses and pathologies occurring in MBP-1 2/2 /EPX 2/2 mice after 1) ovalbumin sensitization/provocation in an acute allergen-challenge protocol, and 2) crossing MBP-1 2/2 /EPX 2/2 mice with a double-transgenic model of chronic type 2 inflammation (i.e., I5/hE2). Acute allergen challenge and constitutive cytokine/chemokine expression each induced the accumulation of pulmonary eosinophils in wild-type controls that was abolished in the absence of MBP-1 and EPX (i.e., MBP-1
Introduction
The unresolved and potentially underappreciated roles of eosinophils in allergic respiratory disease have been driving forces toward the creation of disease-management approaches for patients that efficaciously target these cells (reviewed in [1, 2] ). This unresolved character of eosinophil-mediated events is likely a consequence of the wider array of eosinophil activities recently identified in several studies. Specifically, in addition to tissuedamaging activities (reviewed in [3] ), eosinophils appear to be important regulatory cells capable of modulating pulmonary immune responses and remodeling/repair events in the lung [4] [5] [6] [7] . In particular, studies using the available congenitally eosinophil-deficient strains of mice, PHIL [8] and DdblGATA [9] , and the inducible eosinophil-deficient strain, iPHIL [10] , have each suggested that pulmonary eosinophils appear to mediate a variety of immune responses and/or events, including T effector cell recruitment [11, 12] , the polarization of immune responses by suppression of Th1/Th17 pathways [13] , and the expression of Th2-associated cytokines and chemokines [14, 15] . Despite these data, issues of concern have surrounded eosinophil-deficient strains of mice and may have led to differences in reported data (see e.g., [16] [17] [18] ), obscuring the definition of eosinophil effector functions and their role in health and disease.
Our studies of eosinophil granule proteins and their roles as eosinophil-derived mediators of inflammation have led to the creation of knockout mice deficient in each of the abundant granule proteins, MBP-1 [19] and EPX [20] . Surprisingly, the singular loss of each of those granule proteins had no demonstrable effects on the pulmonary changes linked with acute allergen sensitization/airway challenge. Our subsequent attempts to breed those knockout mice led to the discovery that the eosinophilopoietic capacity of mice was absolutely dependent on the expression of both of those abundant granule protein genes. That is, double-knockout mice deficient in both MBP-1 and EPX (i.e., MBP-1 2/2 /EPX 2/2 mice) are eosinophil deficient with no observable effects on any of the other leukocyte lineages [21] . We further showed in that study that the dependency of eosinophilopoiesis on granule biogenesis was mechanistically the result of targeting the survival of eosinophil marrow progenitors. Moreover, recent studies by other groups support our linkage of eosinophil production with the expression of granule constituents [22, 23] . Thus, the availability of MBP-1
2/2
/EPX 2/2 mice offers an important alternative model system with which to define eosinophilmediated events. In particular, the novel, multigene targeting of eosinophils in this strain that results in the specific loss of eosinophils is accomplished without confounding issues, such as the expression of cytotoxins [17] or altering the expression of transcription factors in multiple leukocyte lineages [16] . We capitalized on the availability of those double-knockout mice to reexamine and further define the role of pulmonary eosinophils in both an acute setting after allergen provocation and a chronic type 2-driven setting resulting from the ectopic expression of the eosinophil agonist cytokine IL-5 and chemokine eotaxin-2 (I5/hE2 mice [24, 25] ). These data confirmed that the presence of pulmonary eosinophils was necessary for the induction of airway type 2 cytokine expression (i.e., IL-4 and IL-13) in the lungs of mice that, in turn, appeared to be responsible for the inflammatory changes and lung dysfunction that occurred after acute allergen challenge of eosinophil-sufficient WT mice. Moreover, our data with the I5/hE2 chronic type 2 inflammatory model showed that the selective targeting of eosinophils occurring in MBP-1
mice reduced pulmonary fibrosis and all but eliminated the goblet cell metaplasia occurring in that model. Collectively, these data support the hypothesis that eosinophils are important regulatory cells that modulate the immune responses and remodeling/repair events in the lung and highlight underappreciated activities contributing to the pulmonary pathologies linked with allergic inflammatory settings. 
MATERIALS AND METHODS

Mice
Induction of allergic airway inflammation
Mice were sensitized and challenged with chicken OVA, as previously described [24] . Mice were assessed for pulmonary/airway cellular infiltrates, eosinophil degranulation, histopathologies, and lung function on d 28 (i.e., 2 d after the last OVA challenge) in this protocol.
Histopathologic evaluations
Formalin-fixed, paraffin-embedded lungs were sectioned and stained with H&E for general morphology and global assessments of inflammation (i.e., qualitative assessments of cellular infiltrates and gross morphologic changes). Masson's Trichrome was used to visualize collagen deposition. In some cases, the extent of the collagen deposition among the groups of mice examined was quantified with Picrosirius red-stained slides imaged in polarized light [25] . Briefly, under polarized light, the submucosal, interstitial area surrounding all central airways within the entire pulmonary parenchyma represented in coronal lung sections from n = 7-11 mice/group was evaluated at a magnification of 3200 (i.e., 6-21 central airways/section, evaluating all airways #0.7 mm in diameter). The extent and intensity of Picrosirius red staining was quantified as the sum total (S) of pixel values (Pixel number 3 Average pixel intensity within the region surrounding the basement membrane of a given central airway), normalized to the total length of central airway basement membrane evaluated. PAS was used to visualize and quantify airway epithelial cell mucin accumulation. Specifically, mucin quantifications inside airway epithelial cells were performed according to a previously published algorithm [27] and expressed as a Mucus index. All evaluations were performed in duplicate as independent, observer-blinded assessments. Image analyses were performed with ImagePro Plus software (Media Cybernetics, Rockville, MD, USA) and ImageJ (U.S. National Institutes of health, https://imagej.nih.gov/ij/).
Lung function assessments
Assessments of baseline airway resistance and airway hyperresponsiveness to a nonspecific agonist were performed with a forced ventilation technique (FlexiVent, SCIREQ, Montreal, QC, Canada) as previously described [8] . Briefly, mice were treated with pentobarbital (90 mg/g of body weight; Nembutal sodium solution; Oak Pharmaceuticals, Lake Forest, IL, USA) and pancuronium bromide (0.5 mg/g of body weight; Sigma-Aldrich, St. Louis, MO, USA), intubated, and after baseline airflow assessments, subjected to increasing doses of aerosolized methacholine (Sigma-Aldrich). A singlefrequency "SnapShot-150" maneuver was used to obtain values of airway dynamic resistance that fit a single-compartment model. The peak responses were used to create the methacholine dose-response curves presented.
Assessment of blood, tissue, and airway eosinophilia
Bone marrow brush smears, peripheral blood films, and cytospins were prepared as previously described [28] . Hematologic evaluations were performed with slides stained with a Romanowsky dye set (Diff-Quik; Siemens, Munich, Germany) to visualize eosinophils based on dye staining and nuclear morphology. Eosinophils were also visualized and quantified by immunohistochemistry with a rat anti-mouse eosinophil-associated ribonuclease mAb (MT3-25.1.1) that recognizes mouse eosinophil-associated ribonucleases Ear-1, -2, -6/7, and -5/11 [21] . Sections were counterstained with methyl green to highlight tissue architecture. Flow cytometric assessments of eosinophils were performed on a BD LSRFortessa (BD Biosciences, Franklin Lakes, NJ, USA) and analyzed with the FlowJo software package (Tree Star, Ashland, OR, USA) 
Statistical analysis
Data were analyzed and plotted using GraphPad Prism 6 (GraphPad Software, La Jolla, CA, USA). ANOVA and Tukey's method were used for multiple group comparisons. The differences among means were considered significant at P , 0.05. The results were plotted as means 6 SEM.
RESULTS
Baseline eosinophil levels in MBP-1
mice were comparable to congenitally eosinophil-deficient mice
We have previously demonstrated that the concurrent loss of MBP-1 and EPX disrupts eosinophilopoiesis through a mechanism promoting the turnover of lineage-committed progenitors [21] . The presence of eosinophils at homeostatic baseline in both the bone marrow and peripheral circulation of MBP-1 2/2 /EPX 2/2 mice was put into context by concurrently performing similar assessments in WT and congenitally eosinophil-deficient PHIL [8] and DdblGATA [9] mice. Romanowsky-stained slide preparations revealed that eosinophils and their progenitors were abundantly present and readily visible in the bone marrow of WT mice (Fig. 1A) . However, the concurrent loss of MBP-1 and EPX in double-knockout mice represented an obstacle to that staining and the unambiguous identification of eosinophils. That is, the unambiguous identification is difficult to accomplish because the abundant granule proteins are the bulk of the cationic characteristics of the granules, which is responsible for the eosin staining of those granulocytes with Romanowsky-based dye sets. That same loss of granule proteins also prevented using either of the gold standard granule protein Abs available to detect tissue-infiltrating eosinophils, anti-MBP-1 [8] m and anti-EPX [29] . Thus, stained marrow preparations appeared to show that, similar to congenitally eosinophil-deficient strains of mice (i.e., PHIL and DdblGATA), MBP-1 2/2 /EPX 2/2 mice were also deficient in eosinophil-lineage-committed cells. Our solution to these logistical issues was the use of yet another granule protein-specific Cell counts and hematologic cell differentials of peripheral blood films showed that MBP-1 2/2 /EPX 2/2 mice have an eosinophil deficiency (without effects on the composition of the other prominent leukocytes, which was equivalent to the deficiency observed in the established, engineered strains of mice congenitally deficient in eosinophils (i.e., PHIL [8] and ΔdblGATA [9] mice). The data presented are expressed as means 6 SEM; n = 6-9 mice/genotype. mAb we created, which recognizes the collective group of eosinophil-associated ribonucleases (i.e., Ears [30] ). Those data confirmed our classic hematologic assessments in a more direct fashion by immunohistochemical staining of femoral bone marrow sections; eosinophil-lineage-committed cells represented 8-12% of the hematopoietic compartment cells [28] . The bone marrow from the two congenitally eosinophil-deficient strains (i.e., PHIL and DdblGATA) demonstrated that they were generally devoid of eosinophils and their progenitors (Fig. 1A) . Interestingly, the eosinophil-deficiency, mediated by the loss of MBP-1 and EPX gene expression (i.e., MBP-1 2/2 /EPX 2/2 ), resulted in a similar, but less absolute, ablation of eosinophils from the marrow compartment relative to the established eosinophil-deficient strains of mice (Fig. 1A) mice relative to the OVA-challenged, WT mice (Fig. 3A) . In particular, a quantitative assessment of GM/MA in these mice showed that the loss of eosinophils in MBP-1 2/2 /EPX 2/2 mice resulted in an ;60% decrease in the GM/MA relative to OVAsensitized/airway-challenged, WT animals (Fig. 3A) . The loss of GM/MA in MBP-1
/EPX 2/2 mice was also accompanied by significant reductions in the allergen-induced type 2 cytokines most often linked with goblet metaplasia: IL-4 ( Fig. 3B; 6 .0 6 1.0 pg/ml vs. 1.6 6 0.3 pg/ml, respectively) and IL-13 ( Fig. 3C ; 104.4 6 15.7 pg/ml vs. 39.4 6 9.4 pg/ml, respectively). Cytokines associated with Th1 (e.g., IFN-g) and Th17 (e.g., IL-17) were undetectable.
Induced AHR in OVA-challenged mice is abolished in eosinophil-deficient MBP-1
Invasive measurements of lung function were performed to define any potential contribution of eosinophils to the mice. The data are expressed as means 6 SEM (n = 3-5 mice). *P , 0.05.
methacholine-induced AHR that occurs after OVA airway challenge. Those data showed that, similar to what was observed with PHIL [8] and DdblGATA [9] mice, the loss of eosinophils in MBP-1 2/2 /EPX 2/2 mice abolished the allergen-induced AHR that occurred in eosinophil-sufficient, WT mice after OVA challenge (Fig. 4) .
Targeted deletion of EPX and MBP-1 is a sufficient eosinophilopoietic blockade preventing the induced pulmonary eosinophilia associated with constitutive IL-5 and eotaxin-2 overexpression in transgenic mice
The link between eosinophils, pulmonary inflammation, and type 2 cytokine expression was further defined by crossing MBP-1 2 /2 /EPX 2 /2 mice with a double-transgenic model of chronic type 2 pulmonary inflammation. Those mice (i.e., I5/hE2 [24, 25] ) constitutively expressed IL-5 from all mature T cells and concurrently overexpressed eotaxin-2 from lung Clara (club) cells. In this model, the IL-5-mediated eosinophilopoietic pressure on the marrow of I5/hE2 mice was both significant and chronic [31] . Moreover, the robust, constitutive overexpression of eotaxin-2 from lung Clara (club) cells elicited and maintained a prominent pulmonary eosinophilia. Collectively, the ectopic overexpression of these eosinophil agonists promoted a significant lung phenotype, characterized by histopathologies, pulmonary dysfunction, and the induced expression of the type 2 cytokines IL-4 and IL-13 [25] . Moreover, earlier studies showed that all those pathologic manifestations were eosinophil dependent [24, 25] . Histologic assessments of lung sections from compound transgenic-gene knockout mice deficient in MBP-1 and EPX (i.e., I5/hE2/MBP-1 2/2 /EPX 2/2 mice) showed that even the constitutive overexpression of IL-5 and eotaxin-2 was unable to overcome the disruption of eosinophilopoiesis caused by the loss of MBP-1 and EPX (Fig. 5A) /EPX 2/2 mice, which displayed a significant decrease in total BAL cells (Fig. 5B ) that accompany a 99% decrease in the induced airway eosinophilia (Fig. 5C ).
Eosinophil deficiency linked with I5/hE2/MBP-1 2/2 / EPX 2/2 mice is sufficient to abolish pulmonary pathologies and lung remodeling events that accompany induced, type 2 cytokine expression occurring in the lungs of the parental I5/hE2 model H&E-stained lung sections (Fig. 5A) showed that, similar to targeting eosinophils in I5/hE2 mice through crosses with either of the congenital eosinophil-deficient strains of mice (i.e., I5/hE2/PHIL [24] or I5/hE2/DdblGATA [32] mice (see Fig. 3 ), resulted in significant decreases in the airway levels of both IL-4 ( Fig. 6B ; 212.2 6 10.3 pg/ml vs. 16.0 6 5.3 pg/ml, respectively) and IL-13 ( Fig. 6C ; 97.9 6 8.1 pg/ml vs. 6.6 6 2.1 pg/ml, respectively). Assessments of cytokines characteristic of Th1 (e.g., IFNg) and Th17 (e.g., IL-17) immune responses were undetectable mice was associated with a significantly reduced allergen-induced methacholine response after allergen challenge. Aerosolized methacholine-induced airway resistance was assessed with an invasive ventilatorbased technique (FlexiVent; SCIREQ). C57BL/6J WT mice challenged with saline alone served as negative controls for these studies. In contrast to WT OVA-sensitized/airway-challenged mice, which displayed typical dose-dependent patterns of increased sensitivity/reactivity in response to methacholine provocation, those changes were abolished in OVA-treated MBP-1 [25] . Namely, qualitative assessments of collagen deposition using MT-stained lung sections suggested that the loss of eosinophils in I5/hE2/MBP-1
2/2
/EPX 2/2 mice was accompanied by a decrease in pulmonary fibrosis relative to the parental I5/hE2 chronic inflammatory model (Fig. 7A) . This suggestion was confirmed quantitatively by the evaluation of Picrosirius red-stained sections under polarized light (Fig. 7B ), which revealed a significant decrease in airway collagen deposition in I5/hE2/MBP-1 (Fig. 8) .
The ablation was virtually complete, reducing the methacholine dose-dependent curve to levels observed in allergen-naïve, WT control mice as well as eosinophil-deficient I5/hE2/PHIL mice [24] . Interestingly, I5/hE2/MBP-1 2/2 /EPX 2/2 mice also displayed a significant improvement in baseline airway resistance relative to the parental I5/hE2 model (0.70 6 0.03 vs. 0.97 6 0.08 cm H 2 O 3 s/ml, respectively; P , 0.05), suggesting a role for eosinophil-mediated remodeling activities leading to fixed airway obstruction in chronic settings. 
DISCUSSION
The first generations of congenitally eosinophil-deficient mice [8, 9] have been remarkable tools with which investigators have finally been able to begin the process of defining specific, eosinophil-mediated activities of functional significance. These mice have allowed "Koch postulates-like" studies to establish a causative relationship between eosinophils and a given disease setting, particularly their role(s) in asthma and other allergic diseases. Despite the value of these mice, some concerns have arisen that require caution when using these early models. For example, PHIL [8] mice have achieved their eosinophil-less character through the expression of diphtheria toxin. Although this strain of mice has been shown to uniquely target eosinophils with no demonstrable effects on other hematopoietic cell lineages, some have argued that the presence of diphtheria toxin may have cell-killing consequences beyond eosinophils that are not predictable on first principles [17] . DdblGATA mice achieved their eosinophil-less character by targeting an autoregulatory loop controlling the expression of a key transcription factor (i.e., GATA1). These mice have also been shown to specifically target eosinophil lineage-committed cells; however, the data in the initial article describing this strain have shown that other hematopoietic cells are affected, including erythroblasts and mast cells [26] , and subsequent studies demonstrated effects on the number and activities of basophils [16] . The availability of eosinophil-deficient MBP-1 2/2 /EPX 2/2 mice [33] now offers a logistical solution to the short-comings of previous congenitally eosinophil-deficient models. That is, unlike PHIL, eosinophil deficiency is not achieved through the expression of a cytocidal protein and thus avoids potential confounding secondary effects mediated by the toxin. Moreover, the unique specificity of the eosinophil ablation in MBP-1 2/2 /EPX 2/2 mice is achieved by targeting 2 independent genes; both of which must be concurrently expressed in the same cell. In this case, although EPX expression is eosinophil specific [8] , MBP-1 appears also to be expressed in basophils [34] and mast cells [35] . However, the only cells expressing both MBP and EPX are eosinophillineage-committed leukocytes. As a result, the eosinophil ablation in MBP-1 2/2 /EPX 2/2 mice arguably displays the greatest degree of eosinophil specificity of all the congenitally eosinophil-deficient strains of mice, with no direct and/or indirect effects on any other cell type [21] . In addition, similar to the earlier strains of eosinophil deficiency, the data here showed that MBP-1 2/2 /EPX 2/2 mice maintained their eosinophil-less character despite eosinophilopoietic pressures mediated by allergen sensitization/airway challenge or ectopic IL-5 overexpression, allowing their broad use in models of disease settings. The studies presented here, using both acute allergen challenge with OVA and a chronic constitutive cytokine/ chemokine transgenic model, each confirm the observations and now growing importance of the abilities of eosinophils to modulate the pulmonary immune microenvironment. Specifically, early studies using PHIL [8] and iPHIL [10] as well as DdblGATA [15] mice each showed that the loss of pulmonary IL-4 and IL-13 expression was a singularly prominent effect of losing eosinophils during an acute airway-challenge protocol. This underappreciated activity was further explored using eosinophil-adoptive transfer studies in the context of an allergen challenge of PHIL mice [13, 14] and through crosses of PHIL [24] and DdblGATA [32] with the I5/hE2 transgenic model of chronic type 2 pulmonary inflammation. Our studies of MBP-1 2/2 /EPX 2/2 mice confirm this very important observation, suggesting that, in addition to other known leukocytes that express IL-4 and/or IL-13 in the lung (e.g., ILC2s [36] and CD4 + T cells [37] ), eosinophils directly or indirectly (through effects on "third-party" cells) contribute to the expression of pulmonary Th2 cytokines. Furthermore, that contribution appears to be important because the loss of eosinophils in OVA treatment of MBP-1 2/2 /EPX 2/2 mice and the cross of MBP-1 2/2 /EPX 2/2 with I5/hE2 mice both result in significant loss of the induced IL-4/-13 pulmonary expression occurring in these settings and, in turn, the loss of lung pathologies linked with the expression of these type 2 cytokines (e.g., AHR, GM/MA, and increased collagen deposition/ fibrosis). represent a significant eosinophil-mediated activity that enhances this IL-13-dependent event and thus may contribute to disease pathologies in settings in which degranulation occurs (e.g., in the airways of patients with allergic asthma). In summary, the induced loss of eosinophils that occurs in the absence of MBP-1 and EPX has again demonstrated the significance of eosinophil-mediated immune regulatory activities in the lung as part of both acute and chronic respiratory inflammation. Moreover, the definitive specificity of the lineage ablation and the magnitude of eosinophil ablation occurring in MBP-1 2/2 /EPX 2/2 mice provide a unique model with which to explore the potential importance of eosinophils and eosinophilmediated activities in health and disease. 
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